piracetam has been researched along with ucb 34714 in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 18 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Differding, E; Frycia, AM; Fuks, B; Gillard, MR; Kenda, BM; Klitgaard, HV; Lallemand, BI; Matagne, AC; Michel, P; Moureau, FG; Pasau, PM; Talaga, PE | 1 |
| Miura, Y | 1 |
| Tai, KK; Truong, DD | 1 |
| Kenda, B; Klitgaard, H; Margineanu, DG; Matagne, A; Michel, P | 1 |
| Hamann, M; Richter, A; Sander, SE | 1 |
| Klitgaard, H; Margineanu, DG | 1 |
| Frycia, A; Jadot, S; Kenda, B; Lallemand, B; Leclercq, K; Lo Brutto, P; Matagne, A; Mercier, J; Starck, JP; Verbois, V | 1 |
| Gevins, A; Leese, PT; Loring, DW; Meador, KJ; Otoul, C | 1 |
| Kleinebudde, P; Kuntz, T; Schubert, MA | 1 |
| Borghs, S; D'Souza, J; Eckhardt, K; Fakhoury, T; Liang, W; Yates, SL | 1 |
| Bognar, J; Dubinsky, JM; Esguerra, M; He, T; Mohammed, M; Niespodziany, I; Rothman, SM; Wolff, C; Yang, X | 1 |
| Carson, RE; Chanteux, H; Hannestad, J; Holden, D; Huang, Y; Kervyn, S; Klitgaard, H; Matagne, A; Mathy, FX; Mercier, J; Nabulsi, N; Nicolas, JM; Staelens, L; Stockis, A; Tytgat, D | 1 |
| Andermann, E; Andermann, F; de la Loge, C; Frucht, SJ; Genton, P; Gerard, D; Kälviäinen, R; Magaudda, A; Schlit, AF; von Rosenstiel, P | 1 |
| Li, H; Li, S; Zhang, L; Zou, X | 1 |
| Ben-Menachem, E; Eckhardt, K; Gamage, J; Johnson, ME; Klein, P; Mameniškienė, R; McDonough, B; Quarato, PP; Schiemann, J; Whitesides, J | 1 |
| Borghs, S; Brandt, C; Charokopou, M; Klein, P | 1 |
| Lin, Z; Xiaoyi, Z | 1 |
| Rogawski, MA | 1 |
| Gillard, M; Wood, MD | 1 |
| Danish, A; Müller, CE; Namasivayam, V; Schiedel, AC | 1 |
| Bacher, M; Bucurenciu, I; Hillenbrand, B; Intravooth, T; Kornmeier, R; Kurth, C; Staack, AM; Steinhoff, BJ; Stockinger, J | 1 |
| Citraro, R; Mula, M; Russo, E | 1 |
| Borghs, S; Fang, A; Plumb, J; Signorovitch, J; Swallow, E | 1 |
| Hintz, M; Hirsch, M; Schulze-Bonhage, A; Specht, A | 1 |
5 review(s) available for piracetam and ucb 34714
| Article | Year |
|---|---|
[A new aspect in the research on antiepileptic drugs].
Topics: Acetamides; Amines; Animals; Anticonvulsants; Benzodiazepines; Carbamates; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Humans; Lacosamide; Levetiracetam; Phenylenediamines; Piracetam; Pregabalin; Pregnanolone; Pyrrolidinones; Triazoles | 2007 |
Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison.
Topics: Adult; Anticonvulsants; Epilepsies, Partial; Humans; Levetiracetam; Outcome Assessment, Health Care; Piracetam; Pyrrolidinones | 2016 |
Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison.
Topics: Adult; Anticonvulsants; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Pyrrolidinones | 2016 |
Response to "Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison".
Topics: Adult; Anticonvulsants; Female; Humans; Levetiracetam; Male; Piracetam; Pyrrolidinones; Seizures | 2016 |
The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy.
Topics: Adult; Animals; Anticonvulsants; Drug Discovery; Epilepsies, Partial; Humans; Levetiracetam; Ligands; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Solubility | 2017 |
5 trial(s) available for piracetam and ucb 34714
| Article | Year |
|---|---|
Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam.
Topics: Adolescent; Adult; Anticonvulsants; Blood Cell Count; Cognition; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Humans; Levetiracetam; Lorazepam; Male; Memory, Short-Term; Mental Recall; Middle Aged; Neuropsychological Tests; Piracetam; Pyrrolidinones; Sample Size; Treatment Outcome; Young Adult | 2011 |
An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Male; Mental Disorders; Middle Aged; Piracetam; Prospective Studies; Pyrrolidinones; Quality of Life; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Young Adult | 2015 |
Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.
Topics: Adolescent; Adult; Anticonvulsants; Clonazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fructose; Humans; Isoxazoles; Levetiracetam; Male; Middle Aged; Phenobarbital; Piracetam; Pyrrolidinones; Topiramate; Treatment Outcome; Unverricht-Lundborg Syndrome; Valproic Acid; Young Adult; Zonisamide | 2016 |
Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Pyrrolidinones; Seizures; Young Adult | 2016 |
Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?
Topics: Adult; Anticonvulsants; Databases, Bibliographic; Double-Blind Method; Epilepsies, Partial; Female; Humans; Levetiracetam; Longitudinal Studies; Male; Middle Aged; Piracetam; Placebo Effect; Pyrrolidinones; Retrospective Studies; Treatment Outcome | 2017 |
14 other study(ies) available for piracetam and ucb 34714
| Article | Year |
|---|---|
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.
Topics: Acoustic Stimulation; Amides; Animals; Anticonvulsants; Binding Sites; Butyrates; Caco-2 Cells; Cerebral Cortex; Crystallography, X-Ray; Female; Humans; In Vitro Techniques; Levetiracetam; Male; Mice; Mice, Inbred DBA; Microsomes, Liver; Models, Molecular; Molecular Conformation; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Seizures; Structure-Activity Relationship | 2004 |
Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsies, Myoclonic; Heart Arrest; Hypoxia; Levetiracetam; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Seizures | 2007 |
Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroshock; Epilepsy; Hippocampus; Levetiracetam; Ligands; Male; Membrane Glycoproteins; Mice; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Seizures | 2008 |
Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster.
Topics: Animals; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Humans; Levetiracetam; Ligands; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Severity of Illness Index | 2008 |
Brivaracetam inhibits spreading depression in rat neocortical slices in vitro.
Topics: Animals; Anticonvulsants; Cortical Spreading Depression; Dose-Response Relationship, Drug; In Vitro Techniques; Levetiracetam; Male; Neocortex; Piracetam; Potassium Chloride; Pyrrolidinones; Rats; Rats, Sprague-Dawley | 2009 |
Discovery of indolone acetamides as novel SV2A ligands with improved potency toward seizure suppression.
Topics: Acetamides; Animals; Anticonvulsants; Disease Models, Animal; Indoles; Levetiracetam; Ligands; Membrane Glycoproteins; Mice; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Rats; Seizures; Synaptic Vesicles | 2010 |
Increased compactibility of acetames after roll compaction.
Topics: Central Nervous System Agents; Chemical Phenomena; Drug Compounding; Levetiracetam; Particle Size; Piracetam; Powders; Pressure; Pyrrolidinones; Surface Properties; Tablets | 2011 |
Brivaracetam augments short-term depression and slows vesicle recycling.
Topics: Animals; Anticonvulsants; CA1 Region, Hippocampal; Dose-Response Relationship, Drug; Electrophysiology; Hippocampus; Levetiracetam; Male; Microscopy, Fluorescence; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Synaptic Vesicles | 2015 |
Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Brain; Caco-2 Cells; Dogs; Epilepsy, Reflex; Humans; In Vitro Techniques; Levetiracetam; Macaca mulatta; Membrane Glycoproteins; Mice; Molecular Targeted Therapy; Nerve Tissue Proteins; Permeability; Piracetam; Positron-Emission Tomography; Pyrrolidinones; Rats | 2016 |
A New SV2A Ligand for Epilepsy.
Topics: Animals; Anticonvulsants; Binding Sites; Epilepsies, Partial; Epilepsy, Generalized; Humans; Levetiracetam; Ligands; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Protein Binding; Protein Conformation; Pyrrolidinones | 2016 |
Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
Topics: Anilides; Anticonvulsants; Brain; Dose-Response Relationship, Drug; Drug Interactions; HEK293 Cells; Humans; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Protein Binding; Pyrrolidinones; Radioligand Assay; Time Factors; Transfection; Tritium | 2017 |
Interaction of Approved Drugs with Synaptic Vesicle Protein 2A.
Topics: Animals; Anticonvulsants; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Humans; Levetiracetam; Ligands; Loratadine; Membrane Glycoproteins; Molecular Structure; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Quinine; Structure-Activity Relationship | 2017 |
Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-A monocenter survey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Drug Substitution; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Pyrrolidinones; Treatment Failure; Treatment Outcome; Young Adult | 2017 |
Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Pyrrolidinones; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |